COVID-19 prevalence and outcomes in patients receiving biologic therapies at an infusion center in New York City

To better understand COVID-19 infection in patients receiving biologic and immunomodulatory therapies, we evaluated prevalence and outcomes for symptomatic cases of COVID-19 at a large therapeutic infusion center in New York City during the height of the pandemic. 2074 patients received treatment wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Kaoru, Ho, Hsi-en, Cunningham-Rundles, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294696/
https://www.ncbi.nlm.nih.gov/pubmed/34302970
http://dx.doi.org/10.1016/j.clim.2021.108803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294696/
https://www.ncbi.nlm.nih.gov/pubmed/34302970
http://dx.doi.org/10.1016/j.clim.2021.108803

Ejemplares similares